US stocks fall in early trading to give back some of their recent gains
Read more
Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer
CHICAGO and FORT WORTH, Texas, May 31, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), today presented topline results from the
Builder.ai Faked Business With Indian Firm VerSe to Inflate Sales, Sources Say
Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here.Builder.ai, the artificial intelligence startup that recently announced plans to declare bankruptcy, faked business with the Indian social-media startup VerSe Innovation for years to falsely inflate its sales,
Xiaomi's Rapid EV Expansion: May Success
Xiaomi Corp has made significant strides in the electric vehicle market with over 28,000 domestic units delivered in May. This marks a notable achievement for the Chinese company as it broadens its portfolio beyond smartphones into the electric vehicle industry, highlighting the firm’s diversification strategy and market reach.
European Defence Market: Strategic Alignment for Enhanced Capability
Micael Johansson, CEO of Saab, emphasizes the need for alignment in European defence requirements to enhance capability. Speaking at the Shangri-La Dialogue, Johansson highlighted the importance of collaboration beyond U.S. partnerships and developing unmanned capabilities. European nations aim to boost defence spending to address security challenges independently. Read Full
